Van ECK Associates Corp Has $408.67 Million Stock Holdings in Corteva, Inc. (NYSE:CTVA)

Van ECK Associates Corp grew its position in Corteva, Inc. (NYSE:CTVA - Free Report) by 11.6% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 8,528,252 shares of the company's stock after buying an additional 883,161 shares during the period. Van ECK Associates Corp owned 1.21% of Corteva worth $408,674,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Union Savings Bank boosted its stake in Corteva by 58.5% in the third quarter. Union Savings Bank now owns 577 shares of the company's stock valued at $30,000 after acquiring an additional 213 shares during the last quarter. Essex Financial Services Inc. boosted its holdings in Corteva by 3.2% during the third quarter. Essex Financial Services Inc. now owns 6,883 shares of the company's stock worth $352,000 after buying an additional 215 shares during the last quarter. NewSquare Capital LLC grew its position in shares of Corteva by 70.6% during the 3rd quarter. NewSquare Capital LLC now owns 546 shares of the company's stock worth $28,000 after buying an additional 226 shares during the period. Tradewinds LLC. increased its stake in shares of Corteva by 5.1% in the 3rd quarter. Tradewinds LLC. now owns 4,788 shares of the company's stock valued at $245,000 after acquiring an additional 231 shares during the last quarter. Finally, Jeppson Wealth Management LLC raised its position in shares of Corteva by 6.2% in the 3rd quarter. Jeppson Wealth Management LLC now owns 4,300 shares of the company's stock valued at $220,000 after acquiring an additional 250 shares during the period. Institutional investors own 81.54% of the company's stock.

Corteva Stock Performance

Shares of CTVA traded up $0.58 during mid-day trading on Monday, reaching $55.50. The company's stock had a trading volume of 2,347,959 shares, compared to its average volume of 3,512,655. The company has a current ratio of 1.56, a quick ratio of 0.90 and a debt-to-equity ratio of 0.09. The stock has a market cap of $38.79 billion, a P/E ratio of 54.19, a PEG ratio of 1.44 and a beta of 0.77. Corteva, Inc. has a 1-year low of $43.22 and a 1-year high of $61.87. The business has a 50-day simple moving average of $55.28 and a two-hundred day simple moving average of $50.46.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings data on Thursday, February 1st. The company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.06 by $0.09. The firm had revenue of $3.71 billion during the quarter, compared to analysts' expectations of $3.54 billion. Corteva had a net margin of 4.27% and a return on equity of 7.43%. During the same period in the previous year, the business posted $0.16 earnings per share. As a group, equities research analysts anticipate that Corteva, Inc. will post 2.84 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Stockholders of record on Tuesday, June 4th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 1.15%. The ex-dividend date of this dividend is Tuesday, June 4th. Corteva's payout ratio is 62.75%.

Analyst Ratings Changes

CTVA has been the topic of several analyst reports. UBS Group cut their target price on shares of Corteva from $65.00 to $64.00 and set a "buy" rating on the stock in a report on Thursday, January 11th. Barclays increased their price target on Corteva from $55.00 to $58.00 and gave the stock an "equal weight" rating in a report on Wednesday, April 10th. BNP Paribas upgraded Corteva from an "underperform" rating to a "neutral" rating and set a $53.00 price objective on the stock in a report on Friday, February 2nd. KeyCorp raised their target price on shares of Corteva from $63.00 to $66.00 and gave the stock an "overweight" rating in a report on Tuesday, April 9th. Finally, JPMorgan Chase & Co. reissued a "neutral" rating and set a $57.00 price objective (down previously from $58.00) on shares of Corteva in a research report on Friday, April 12th. Six investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $63.29.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.